Effect of drugs on amines in the CNS.
D000588:Amines / Q000378:metabolism*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D000978:Antiparkinson Agents / Q000494:pharmacology; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001679:Biogenic Amines / Q000378:metabolism / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D006885:Hydroxybutyrates / Q000494:pharmacology; D007700:Kinetics; D008660:Metabolism / Q000187:drug effects; D008781:Methyltyrosines / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D011868:Radioisotopes; D012110:Reserpine / Q000494:pharmacology
D000588:Amines; D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001679:Biogenic Amines; D006885:Hydroxybutyrates; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D011868:Radioisotopes; D012110:Reserpine; D000661:Amphetamine; D002746:Chlorpromazine